Neuphoria Therapeutics (NEUP) Other Non-Current Assets (2023 - 2025)

Neuphoria Therapeutics (NEUP) has reported Other Non-Current Assets for 3 consecutive years, with $79647.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Other Non-Current Assets rose 7.66% year-over-year to $79647.0 in Q4 2025; TTM through Dec 2025 was $79647.0, a 7.66% increase from a year earlier, with the FY2025 full-year figure at $77945.0, down 1.12% from the prior year.
• Other Non-Current Assets was $79647.0 for Q4 2025 at Neuphoria Therapeutics, up from $78564.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $82491.0 in Q3 2024 and troughed at $73982.0 in Q4 2024.
• A 3-year average of $78421.1 and a median of $78695.0 in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets dropped 9.11% in 2024 and advanced 7.66% in 2025, its largest moves.
• Over 3 years, Other Non-Current Assets stood at $81396.0 in 2023, then retreated by 9.11% to $73982.0 in 2024, then grew by 7.66% to $79647.0 in 2025.
• The last three Other Non-Current Assets figures came in at $79647.0 (Q4 2025), $78564.0 (Q3 2025), and $77945.0 (Q2 2025), per Business Quant data.